1Melmed S. Pathogenesis of pituitary tumors[J]. Endocrinol Metab Clin North Am, 1999,28:1- 12.
2Machiavelli GA,Rivolta CM, Artese R, et al.Expression of c myc and c fos and binding sites forestradiol and progesterone in human pituitary tumors[J]. Neurol Res, 1998,20(8): 709.
3Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas[J]. Endocrine Rev, 1998,19: 798- 827.
4Hamilton HB,Hinton DR,Law RE,et al.Inhibition of callular growth and induction of apotosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypercicin potential therapeutic application[J].J Neurosurg,1996,85:329- 334.
6Heaney AP,Horwitz GA,Wang Z,et al.Early involvement of estrogen induced pituitary transforming gene and fibroblast growth factor expression in pralactionoma pathogenesis[J]. Nat Med,1999,5(11):1317.
7Shimon I ,Hinton DR,Weiss MH,et al.Prolactinomas express human heparin binding secretory transforming gene(HST) protein product marker invasiveness[J]. Clin Endocrinol(Oxf),1998,48(1):23- 29.
8Takino H,Herman V,Weiss M,et al.Purine binding factor(nm23) gene expression in pituitary tumors:marker of adenoma invasiveness[J]. J Clin Endocrinol Metab,1995,80(5):1733.
9Pei L,Melmed S,Scheithauer B,et al.Frequentloss of heterozygosity at the retinoblastoma susceptibility gene(Rb) focus in aggressive pituitary tumors: evidence for a chormosome 13 tumor suppressor gene other than RB[J].Cancer Res,1995,55:1613- 1616.
10Thapar K,Scheithauer BW,Kavacs K,et al. p53 expression in pituitary adenomas and carcinomas: correlation with invassiveness and tumor growth fractions[J].Neurosurg,1996,38: 765- 771.
